GERON CORP Restricted Investments, at Fair Value
GERON CORP (GERN) had Restricted Investments, at Fair Value of $1.89 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes
us-gaap:RestrictedInvestmentsAtFairValue · last filed 2026-08-05
- 2026-06-30: Restricted Investments, at Fair Value $1.89M.
- 2026-03-31: Restricted Investments, at Fair Value $1.88M.
- 2025-12-31: Restricted Investments, at Fair Value $1.88M.
- 2025-09-30: Restricted Investments, at Fair Value $1.88M.
| Period end | Restricted Investments, at Fair Value |
|---|---|
| 2026-06-30 | $1.89M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $1.88M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $1.88M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $1.88M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $1.87M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $1.86M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $1.86M 10-K · filed 2026-03-02 |
| 2024-09-30 | $1.85M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.12M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.12M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $1.11M 10-K · filed 2025-02-27 |
| 2023-06-30 | $535.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $365.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $364.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $364.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $364.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $364.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $364.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $363.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $363.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $363.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $363.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $363.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $363.00K 10-Q · filed 2020-08-06 |
| 2017-06-30 | $268.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $268.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $268.00K 10-Q · filed 2017-08-09 |
| 2016-09-30 | $268.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $267.00K 10-Q · filed 2016-08-03 |
| 2016-03-31 | $267.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $267.00K 10-K · filed 2017-03-01 |
| 2015-09-30 | $266.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $266.00K 10-Q · filed 2015-08-05 |
| 2015-03-31 | $266.00K 10-Q · filed 2015-05-07 |
| 2014-12-31 | $266.00K 10-K · filed 2016-03-10 |
| 2014-09-30 | $265.00K 10-Q · filed 2014-11-05 |
| 2014-06-30 | $795.00K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $795.00K 10-Q · filed 2014-05-01 |
| 2013-12-31 | $795.00K 10-K · filed 2015-03-11 |
| 2013-09-30 | $795.00K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $795.00K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $794.00K 10-Q · filed 2013-05-03 |
| 2012-12-31 | $794.00K 10-K · filed 2014-03-17 |
| 2011-12-31 | $793.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |